Ubiquitination-dependent quality control of hERG K+ channel with acquired and inherited conformational defect at the plasma membrane

Molecular Biology of the Cell

Volumn 24, Issue 24, 2013, Pages 3787-3804

  Apaja, Pirjo M ^a   Foo, Brian ^a   Okiyoneda, Tsukasa ^a   Valinsky, William C ^a   Barriere, Herve ^a   Atanasiu, Roxana ^a   Ficker, Eckhard ^a   Lukacs, Gergely L ^a   Shrier, Alvin ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIAC GLYCOSIDE; CHAPERONE; ESCRT PROTEIN; HEAT SHOCK PROTEIN 70; POTASSIUM CHANNEL HERG; CARDIOTONIC AGENT; CATION TRANSPORT PROTEIN; DIGOXIN; ENZYME INHIBITOR; HSPBP1 PROTEIN, HUMAN; OUABAIN; POTASSIUM; SIGNAL TRANSDUCING ADAPTOR PROTEIN; SMALL INTERFERING RNA;

ANIMAL CELL; ARTICLE; CELL MEMBRANE; CELL SURFACE; CONTROLLED STUDY; CYTOSOL; DEGRADATION; DISEASE COURSE; DOWN REGULATION; FEMALE; GLYCOSYLATION; HUMAN; HUMAN CELL; HYPOKALEMIA; INTERNALIZATION; LONG QT SYNDROME 2; LYSOSOME; MISSENSE MUTATION; MOUSE; NONHUMAN; POTASSIUM CELL LEVEL; POTASSIUM DEPLETION; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN STRUCTURE; QUALITY CONTROL; UBIQUITINATION; BIOSYNTHESIS; GENETICS; HEART; HEK293 CELL LINE; HELA CELL LINE; LONG QT SYNDROME; METABOLISM; PATCH CLAMP TECHNIQUE; PHYSIOLOGY; PROTEIN FOLDING; PROTEIN TRANSPORT; RNA INTERFERENCE; TUMOR CELL LINE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; CARDIAC GLYCOSIDES; CARDIOTONIC AGENTS; CATION TRANSPORT PROTEINS; CELL LINE, TUMOR; CELL MEMBRANE; DIGOXIN; DOWN-REGULATION; ENDOSOMAL SORTING COMPLEXES REQUIRED FOR TRANSPORT; ENZYME INHIBITORS; ETHER-A-GO-GO POTASSIUM CHANNELS; HEART; HEK293 CELLS; HELA CELLS; HUMANS; LONG QT SYNDROME; OUABAIN; PATCH-CLAMP TECHNIQUES; POTASSIUM; PROTEIN FOLDING; PROTEIN TRANSPORT; RNA INTERFERENCE; RNA, SMALL INTERFERING; UBIQUITINATION;

EID: 84890492956     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E13-07-0417     Document Type: Article

References (66)

1. Akhavan A, Atanasiu R, Shrier A (2003). Identification of a COOH-terminal segment involved in maturation and stability of human ether-A-go-go-related gene potassium channels. J Biol Chem 278, 40105-40112.
2. Albesa M, Grilo LS, Gavillet B, Abriel H (2011). Nedd4-2-dependent ubiquitylation and regulation of the cardiac potassium channel hERG1. J Mol Cell Cardiol 51, 90-98.
3. Anderson CL, Delisle BP, Anson BD, Kilby JA, Will ML, Tester DJ, Gong Q, Zhou Z, Ackerman MJ, January CT (2006). Most LQT2 mutations reduce Kv11.1 (hERG) current by a class 2 (trafficking-deficient) mechanism. Circulation 113, 365-373.
4. Apaja PM, Xu H, Lukacs GL (2010). Quality control for unfolded proteins at the plasma membrane. J Cell Biol 191, 553-570.
5. Arvan P, Zhao X, Ramos-Castaneda J, Chang A (2002). Secretory pathway quality control operating in Golgi, plasmalemmal, and endosomal systems. Traffic 3, 771-780.
6. Barriere H, Apaja P, Okiyoneda T, Lukacs GL (2011). Endocytic sorting of CFTR variants monitored by single-cell fluorescence ratiometric image analysis (FRIA) in living cells. Methods Mol Biol 741, 301-317.
7. Barriere H, Lukacs GL (2008). Analysis of endocytic trafficking by single-cell fluorescence ratio imaging. Curr Protoc Cell Biol Chapter 15, Unit 15.13.
8. Barriere H, Nemes C, Lechardeur D, Khan-Mohammad M, Fruh K, Lukacs GL (2006). Molecular basis of oligoubiquitin-dependent internalization of membrane proteins in Mammalian cells. Traffic 7, 282-297.
9. Beller GA, Smith TW, Abelmann WH, Haber E, Hood WB Jr. (1971). Digitalis intoxication. A prospective clinical study with serum level correlations. N Engl J Med 284, 989-997.
10. Boehmer C, Laufer J, Jeyaraj S, Klaus F, Lindner R, Lang F, Palmada M (2008). Modulation of the voltage-gated potassium channel Kv1.5 by the SGK1 protein kinase involves inhibition of channel ubiquitination. Cell Physiol Biochem 22, 591-600.
11. Boname JM, Thomas M, Stagg HR, Xu P, Peng J, Lehner PJ (2010). Efficient internalization of MHC I requires lysine-11 and lysine-63 mixed linkage polyubiquitin chains. Traffic 11, 210-220.
12. Brodsky JL, Skach WR (2011). Protein folding and quality control in the endoplasmic reticulum: Recent lessons from yeast and mammalian cell systems. Curr Opin Cell Biol 23, 464-475.
13. Ciechanover A, Gropper R, Schwartz AL (1991). The ubiquitin-Activating enzyme is required for lysosomal degradation of cellular proteins under stress. Biomed Biochim Acta 50, 321-332.
14. Connell P, Ballinger CA, Jiang J, Wu Y, Thompson LJ, Hohfeld J, Patterson C (2001). The co-chaperone CHIP regulates protein triage decisions mediated by heat-shock proteins. Nat Cell Biol 3, 93-96.
15. Cordes JS, Sun Z, Lloyd DB, Bradley JA, Opsahl AC, Tengowski MW, Chen X, Zhou J (2005). Pentamidine reduces hERG expression to prolong the QT interval. Br J Pharmacol 145, 15-23.
16. Cyr DM, Hohfeld J, Patterson C (2002). Protein quality control: U-box-containing E3 ubiquitin ligases join the fold. Trends Biochem Sci 27, 368-375.
17. Delisle BP, Anderson CL, Balijepalli RC, Anson BD, Kamp TJ, January CT (2003). Thapsigargin selectively rescues the trafficking defective LQT2 channels G601S and F805C. J Biol Chem 278, 35749-35754.
18. Dennis AT, Nassal D, Deschenes I, Thomas D, Ficker E (2011). Antidepressant-induced ubiquitination and degradation of the cardiac potassium channel hERG. J Biol Chem 286, 34413-34425.
19. Dennis A, Wang L, Wan X, Ficker E (2007). hERG channel trafficking: novel targets in drug-induced long QT syndrome. Biochem Soc Trans 35, 1060-1063.
20. Dennis AT, Wang L, Wan H, Nassal D, Deschenes I, Ficker E (2012). Molecular determinants of pentamidine-induced hERG trafficking inhibition. Mol Pharmacol 81, 198-209.
21. Du K, Sharma M, Lukacs GL (2005). The DeltaF508 cystic fibrosis mutation impairs domain-domain interactions and arrests post-translational folding of CFTR. Nat Struct Mol Biol 12, 17-25.
22. Duarri A et al. (2008). Molecular pathogenesis of megalencephalic leukoencephalopathy with subcortical cysts: mutations in MLC1 cause folding defects. Hum Mol Genet 17, 3728-3739.
23. Ficker E, Dennis AT, Wang L, Brown AM (2003). Role of the cytosolic chaperones Hsp70 and Hsp90 in maturation of the cardiac potassium channel HERG. Circ Res 92, e87-e100.
24. Ficker E, Kuryshev YA, Dennis AT, Obejero-Paz C, Wang L, Hawryluk P, Wible BA, Brown AM (2004). Mechanisms of arsenic-induced prolongation of cardiac repolarization. Mol Pharmacol 66, 33-44.
25. Furutani M et al. (1999). Novel mechanism associated with an inherited cardiac arrhythmia: defective protein trafficking by the mutant HERG (G601S) potassium channel. Circulation 99, 2290-2294.
26. Gheorghiade M, Lukas MA (2004). Role of carvedilol in atrial fibrillation: insights from clinical trials. Am J Cardiol 93, 53B-57B
27. Glozman R, Okiyoneda T, Mulvihill CM, Rini JM, Barriere H, Lukacs GL (2009). N-glycans are direct determinants of CFTR folding and stability in secretory and endocytic membrane traffic. J Cell Biol 184, 847-862.
28. Guo J, Massaeli H, Li W, Xu J, Luo T, Shaw J, Kirshenbaum LA, Zhang S (2007). Identification of IKr and its trafficking disruption induced by probucol in cultured neonatal rat cardiomyocytes. J Pharmacol Exp Ther 321, 911-920.
29. Guo J, Massaeli H, Xu J, Jia Z, Wigle JT, Mesaeli N, Zhang S (2009). Extracellular K+ concentration controls cell surface density of IKr in rabbit hearts and of the HERG channel in human cell lines. J Clin Invest 119, 2745-2757.
30. Gustina AS, Trudeau MC (2013). The eag domain regulates hERG channel inactivation gating via a direct interaction. J Gen Physiol 141, 229-241.
31. Haardt M, Benharouga M, Lechardeur D, Kartner N, Lukacs GL (1999). C-terminal truncations destabilize the cystic fibrosis transmembrane conductance regulator without impairing its biogenesis. A novel class of mutation. J Biol Chem 274, 21873-21877.
32. Henne WM, Buchkovich NJ, Emr SD (2011). The ESCRT pathway. Dev Cell 21, 77-91.
33. Harley CA, Jesus CS, Carvalho R, Brito RM, Morais-Cabral JH (2012). Changes in channel trafficking and protein stability caused by LQT2 mutations in the PAS domain of the HERG channel. PLoS One 7, e32654.
34. Hauptman PJ, Kelly RA (1999). Digitalis. Circulation 99, 1265-1270.
35. Hawryluk MJ, Keyel PA, Mishra SK, Watkins SC, Heuser JE, Traub LM (2006). Epsin 1 is a polyubiquitin-selective clathrin-Associated sorting protein. Traffic 7, 262-281.
36. Henke G, Maier G, Wallisch S, Boehmer C, Lang F (2004). Regulation of the voltage gated K+ channel Kv1.3 by the ubiquitin ligase Nedd4-2 and the serum and glucocorticoid inducible kinase SGK1. J Cell Physiol 199, 194-199.
37. Keating MT, Sanguinetti MC (2001). Molecular and cellular mechanisms of cardiac arrhythmias. Cell 104, 569-580.
38. Keener JM, Babst M (2013). Quality control and substrate-dependent downregulation of the nutrient transporter Fur4. Traffic 14, 412-427.
39. Ke Y, Ng CA, Hunter MJ, Mann SA, Heide J, Hill AP, Vandenberg JI (2013). Trafficking defects in PAS domain mutant Kv11.1 channels: roles of reduced domain stability and altered domain-domain interactions. Biochem J 454, 69-77.
40. Kim HT, Kim KP, Lledias F, Kisselev AF, Scaglione KM, Skowyra D, Gygi SP, Goldberg AL (2007). Certain pairs of ubiquitin-conjugating enzymes (E2s) and ubiquitin-protein ligases (E3s) synthesize nondegradable forked ubiquitin chains containing all possible isopeptide linkages. J Biol Chem 282, 17375-17386.
41. Krishnan MN, Bingham JP, Lee SH, Trombley P, Moczydlowski E (2005). Functional role and affinity of inorganic cations in stabilizing the tetrameric structure of the KcsA K+ channel. J Gen Physiol 126, 271-283.
42. Kuryshev YA et al. (2005). Pentamidine-induced long QT syndrome and block of hERG trafficking. J Pharmacol Exp Ther 312, 316-323.
43. Lamothe SM, Zhang S (2013). The serum-And glucocorticoid-inducible kinases SGK1 and SGK3 regulate hERG channel expression via ubiquitin ligase Nedd4-2 and GTPase Rab11. J Biol Chem 288, 15075-15084.
44. Lockless SW, Zhou M, MacKinnon R (2007). Structural and thermodynamic properties of selective ion binding in a K+ channel. PLoS Biol 5, e121.
45. MacGurn JA, Hsu PC, Emr SD (2012). Ubiquitin and membrane protein turnover: from cradle to grave. Annu Rev Biochem 81, 231-259.
46. Maier G, Palmada M, Rajamanickam J, Shumilina E, Bohmer C, Lang F (2006). Upregulation of HERG channels by the serum and glucocorticoid inducible kinase isoform SGK3. Cell Physiol Biochem 18, 177-186.
47. Massaeli H, Guo J, Xu J, Zhang S (2010a). Extracellular K+ is a prerequisite for the function and plasma membrane stability of HERG channels. Circ Res 106, 1072-1082.
48. Massaeli H, Sun T, Li X, Shallow H, Wu J, Xu J, Li W, Hanson C, Guo J, Zhang S (2010b). Involvement of caveolin in low K+-induced endocytic degradation of cell-surface human ether-A-go-go-related gene (hERG) channels. J Biol Chem 285, 27259-27264.
49. Meacham GC, Patterson C, Zhang W, Younger JM, Cyr DM (2001). The Hsc70 co-chaperone CHIP targets immature CFTR for proteasomal degradation. Nat Cell Biol 3, 100-105.
50. Okiyoneda T, Apaja PM, Lukacs GL (2011). Protein quality control at the plasma membrane. Curr Opin Cell Biol 23, 483-491.
51. Okiyoneda T, Barriere H, Bagdany M, Rabeh WM, Du K, Hohfeld J, Young JC, Lukacs GL (2010). Peripheral protein quality control removes unfolded CFTR from the plasma membrane. Science 329, 805-810.
52. Rajamani S et al. (2006). Drug-induced long QT syndrome: hERG K+ channel block and disruption of protein trafficking by fluoxetine and norfluoxetine. Br J Pharmacol 149, 481-489.
53. Ren X, Hurley JH (2010). VHS domains of ESCRT-0 cooperate in high-Avidity binding to polyubiquitinated cargo. EMBO J 29, 1045-1054.
54. Sanguinetti MC, Jiang C, Curran ME, Keating MT (1995). A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel. Cell 81, 299-307.
55. Sanguinetti MC, Tristani-Firouzi M (2006). hERG potassium channels and cardiac arrhythmia. Nature 440, 463-469.
56. Sharma M et al. (2004). Misfolding diverts CFTR from recycling to degradation: quality control at early endosomes. J Cell Biol 164, 923-933.
57. Sun T et al. (2011). The role of monoubiquitination in endocytic degradation of human ether-A-go-go-related gene (hERG) channels under low K+ conditions. J Biol Chem 286, 6751-6759.
58. Takemasa H et al. (2008). Coexistence of hERG current block and disruption of protein trafficking in ketoconazole-induced long QT syndrome. Br J Pharmacol 153, 439-447.
59. Vandenberg JI, Perry MD, Perrin MJ, Mann SA, Ke Y, Hill AP (2012). hERG K(+) channels: structure, function, and clinical significance. Physiol Rev 92, 1393-1478.
60. Walker VE, Atanasiu R, Lam H, Shrier A (2007). Co-chaperone FKBP38 promotes HERG trafficking. J Biol Chem 282, 23509-23516.
61. Walker VE, Wong MJ, Atanasiu R, Hantouche C, Young JC, Shrier A (2010). Hsp40 chaperones promote degradation of the HERG potassium channel. J Biol Chem 285, 3319-3329.
62. Wang DT, Hill AP, Mann SA, Tan PS, Vandenberg JI (2011). Mapping the sequence of conformational changes underlying selectivity filter gating in the K(v)11.1 potassium channel. Nat Struct Mol Biol 18, 35-41.
63. Wang L, Dennis AT, Trieu P, Charron F, Ethier N, Hebert TE, Wan X, Ficker E (2009). Intracellular potassium stabilizes human ether-A-go-go-related gene channels for export from endoplasmic reticulum. Mol Pharmacol 75, 927-937.
64. Wang L, Wible BA, Wan X, Ficker E (2007). Cardiac glycosides as novel inhibitors of human ether-A-go-go-related gene channel trafficking. J Pharmacol Exp Ther 320, 525-534.
65. Wible BA, Hawryluk P, Ficker E, Kuryshev YA, Kirsch G, Brown AM (2005). HERG-Lite: a novel comprehensive high-throughput screen for drug-induced hERG risk. J Pharmacol Toxicol Methods 52, 136-145.
66. Zhou Y, MacKinnon R (2003). The occupancy of ions in the K+ selectivity filter: charge balance and coupling of ion binding to a protein conformational change underlie high conduction rates. J Mol Biol 333, 965-975.